A Study Using Botulinum Toxin Type A in Patients With Axillary Hyperhidrosis

Study Identifier
191622-513
CT.gov Identifier
NCT00168480
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Other
    • Study Drug
  • Botulinum Toxin Type A
    • Phase
    Phase 4
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Marked axillary hyperhidrosis
    Exclusion Criteria:
    * Previous use of botulinum toxin for hyperhidrosis

    Protocol Summary

    This is a three year open-label study in subjects with axillary hyperhidrosis.

    Study Locations

    Location
    Status
    Location
    Portland, Oregon, United States
    Status
    Not applicable
    Location
    Pinneberg, Germany
    Status
    Not applicable
    Location
    Gothenburg, Sweden
    Status
    Not applicable
    Location
    Nottingham, United Kingdom
    Status
    Not applicable